NIRvana Sciences Revenue and Competitors
Estimated Revenue & Valuation
- NIRvana Sciences's estimated annual revenue is currently $1.6M per year.
- NIRvana Sciences's estimated revenue per employee is $155,000
Employee Data
- NIRvana Sciences has 10 Employees.
- NIRvana Sciences grew their employee count by 0% last year.
NIRvana Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | President | Reveal Email/Phone |
4 | Scientist | Reveal Email/Phone |
5 | Scientist | Reveal Email/Phone |
6 | Scientist | Reveal Email/Phone |
NIRvana Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is NIRvana Sciences?
Nirvana Sciences is a technology development company spun-out from the Department of Chemistry at North Carolina State University. We are located at First Flight Venture Center in Research Triangle Park, North Carolina USA. Additionally, NIRvana is a recent NC IDEA grant winner and a Blackstone Entrepreneurs Network portfolio company. NIRvana Sciences is commercializing novel fluorescent dyes with ultra-narrow emissions that will increase the performance of fluorescence-based medical diagnostic and imaging systems and tests. Ultra-narrow emission dyes reduce detection complexities; thereby generating more accurate data for clinicians while also increasing multiplexing capabilities highly desired by researchers. Such advancements in detection and sensitivity support the “Fewer Tests, More Answers†trend to derive more actionable data from each patient sample. This will improve the diagnosis and treatment regimens of patients affected by cancer or infectious disease. NIRvana is currently developing strategic partnerships with companies to use our dyes in a wide range of diagnostic and imaging platforms. For more information please visit our website:
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 13 | 0% | N/A |
#2 | $1.3M | 15 | -6% | N/A |
#3 | $3.6M | 31 | -6% | N/A |
#4 | $8.1M | 52 | 0% | N/A |
#5 | $13.7M | 68 | -8% | N/A |